Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg
Conditions
Interventions
Intervention1: Experimental group: 50 PATIENTS UNDERGOING TREATMENT WITH PORTABLE MICROCURRENT STIMULATOR
Control Intervention1: CONTROL GROUP: PATIENTS UNDERGOING TREATMENT WITH REGULAR BETADINE PERO
Sponsors
Dr Rajesh K S
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with chronic foot ulcers Patients willing to participate Patients able to attend regular wound care sessions
Exclusion criteria
Exclusion criteria: Pacemakers or implantable cardioverter-defibrillators (ICDs) Metal implants Pregnancy or breastfeeding Epilepsy or seizure disorders Allergies to electrodes or conductive gels Ulcers with exposed bone, tendon, or joint Patients with Active infection,Necrotic tissue and Poor circulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| : The primary outcome is the percentage reduction in wound surface area from baseline to 12 weeks (or study endpoint), measured via standardized digital planimetry or photography. This was used for sample size estimation to detect a 30-40% greater reduction versus standard care.Timepoint: The primary outcome will be assessed at the following time points: baseline (week 0), 4 weeks, 8 weeks, and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in hospital stay Faster wound healing compared to REGUAL BETADINE dressingTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDR G MUTHU KUMARAN
Saveetha Medical College and Hospital
Outcome results
None listed